A randomized, double-blind, placebo-controlled trial of aripiprazole in the treatment of adolescents with schizophrenia: A report on tolerability

被引：0
|
作者：
Carson, William H. [1 ]
Robb, Adelaide S. [2 ]
Van-Beek, Alet [1 ]
Johnson, Brian
Mallikaarjun, Suresh
Ivanova, Svetlana [1 ]
Forbes, Robert A. [1 ]
Marcus, Ronald N. [3 ]
Nyilas, Margaretta [1 ]
机构：
[1] Otsuka Pharmaceut Dev & Commercializat, Princeton, NJ USA
[2] Childrens Natl Med Ctr, Childrens Res Inst, Washington, DC 20010 USA
[3] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY | 2007年 / 17卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：880 / 881
页数：2
相关论文
共 50 条
  • [31] A double-blind, placebo-controlled study of olanzapine in adolescents with schizophrenia
    Kryzhanovskaya, L
    Schulz, C
    McDougle, CJ
    Frazier, JA
    Dittmann, R
    Robertson-Plouch, C
    Bauer, T
    Xu, W
    Wang, WV
    Carlson, J
    Tohen, M
    SCHIZOPHRENIA RESEARCH, 2006, 81 : 44 - 45
  • [32] A double-blind, placebo-controlled study of olanzapine in adolescents with schizophrenia
    Kryzhanovskaya, L
    Schulz, C
    McDougle, CJ
    Frazier, JA
    Dittmann, R
    Robertson-Plouch, C
    Bauer, T
    Xu, W
    Wang, WV
    Carlson, J
    Tohen, M
    BIOLOGICAL PSYCHIATRY, 2006, 59 (08) : 224S - 224S
  • [33] Randomized, Double-Blind, Placebo-Controlled Trial Demonstrates the Efficacy and Safety of Oral Aripiprazole for the Treatment of Tourette's Disorder in Children and Adolescents
    Sallee, Floyd
    Kohegyi, Eva
    Zhao, Joan
    McQuade, Robert
    Cox, Kevin
    Sanchez, Raymond
    van Beek, Alet
    Nyilas, Margaretta
    Carson, William
    Kurlan, Roger
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (09) : 771 - 781
  • [34] Adjunctive Memantine Treatment of Schizophrenia A Double-Blind, Randomized Placebo-Controlled Study
    Hassanpour, Fatemeh
    Zarghami, Mehran
    Mouodi, Sussan
    Moosazadeh, Mahmood
    Barzegar, Fatemeh
    Bagheri, Maedeh
    Hendouei, Narjes
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2019, 39 (06) : 634 - 638
  • [35] Effect of aripiprazole augmentation of clozapine in schizophrenia: A double-blind, placebo-controlled study
    Muscatello, Maria Rosaria A.
    Bruno, Antonio
    Pandolfo, Gianluca
    Mico, Umberto
    Scimeca, Giuseppe
    Di Nardo, Floriana
    Santoro, Vincenza
    Spina, Edoardo
    Zoccali, Rocco A.
    SCHIZOPHRENIA RESEARCH, 2011, 127 (1-3) : 93 - 99
  • [36] Optimizing Treatment with Lurasidone in Patients with Schizophrenia: Results: of a Randomized, Double-blind, Placebo-controlled Trial (OPTIMIZE Trial)
    Loebel, Antony
    Silva, Robert
    Goldman, Robert
    Watabe, Kei
    Cucchiaro, Josephine
    Kane, John
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 : S476 - S477
  • [37] Adjunctive varenicline treatment for smoking reduction in patients with schizophrenia: A randomized double-blind placebo-controlled trial
    Jeon, Dong-Wook
    Shim, Joo-Cheol
    Kong, Bo-Geum
    Moon, Jung-Joon
    Seo, Young-Soo
    Kim, Sung-Jin
    Oh, Min-Kyung
    Jung, Do-Un
    SCHIZOPHRENIA RESEARCH, 2016, 176 (2-3) : 206 - 211
  • [38] Escitalopram in the treatment of negative symptoms in patients with chronic schizophrenia: A randomized double-blind placebo-controlled trial
    Iancu, Iulian
    Tschernihovsky, Eleonora
    Bodner, Ehud
    Piconne, Anna Sapir
    Lowengrub, Katherine
    PSYCHIATRY RESEARCH, 2010, 179 (01) : 19 - 23
  • [39] Sodium Benzoate Add-on Treatment for Refractory Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Lin, Chieh-Hsin
    Chang, Yue-Cune
    Lane, Hsien-Yuan
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 196 - 196
  • [40] Escitalopram in the treatment of negative symptoms in chronic schizophrenia patients: A randomized double-blind placebo-controlled trial
    Iancu, I.
    Tchernihovsky, E.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2008, 11 : 140 - 140
12345